Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07066501
Starting soon Not applicable

ACT-Based Intervention for Problem Gambling

NCT07066501 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-03
Last updated
2025-07-18

Condition(s) studied

Problem Gambling

Investigational drug(s) / intervention(s)

Acceptance and Commitment Therapy (ACT)

Acceptance and Commitment Therapy (ACT): Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor or defusion training.

Study summary

The goal of this randomized clinical trial is to study if Acceptance and Commitment Therapy (ACT) is effective to treat Problem Gambling in young adults.The main questions it aims to answer are:

* Does ACT therapy improve health and gambling behavior?
* Are the clinical improvements of youth with gambling disorder receiving ACT-based intervention significantly greater than the clinical improvements of youth with gambling disorder on the waiting list?

Researchers will assess whether changes in health, gambling behavior, and other psychological variables are observed after eight weeks of therapy.

Participants will:

* Attend weekly online group sessions for 8 weeks
* Learn new tools that they will put into practice after the sessions
* Be required to complete evaluation questionnaires before and after the intervention and at the 3- and 6-month follow-up

Eligibility

Sex
ALL
Min age
18 Years
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 25 years * Score ≥ 3 on the Problem Gambling Severity Index (PGSI) * Comprehension of Spanish, online connection, and signed consent Exclusion Criteria: * In active psychological or pharmacological treatment for gambling disorder * Having received ACT-based psychological treatment in the last 6 months * Problematic substance use: CAGE Adapted to Include Drugs Questionnaire (CAGE-AID) score ≥ 3 * Difficulty consistently attending online sessions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad Europea de Madrid Villaviciosa de Odón Madrid

More Universidad Europea de Madrid trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07066501 on ClinicalTrials.gov ↗ ← All trials in Spain